SCHEMBL2331090

SCHEMBL2331090

CCCC(CN[C@@H](CC)C(=O)O)CC(=O)OCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
FAAH O00519 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 2/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 2/20 0.33
POLB P06746 2/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2331088 1.00 MGAM (0.36) MGAMGAASIMGAM2FAAH
SCHEMBL2330264 0.88 MGAM (0.36) MGAMGAASIMGAM2FAAH
SCHEMBL2330262 0.88 MGAM (0.36) MGAMGAASIMGAM2FAAH
SCHEMBL2332751 0.88 CHRM1 (0.33) KMT2APOLBCHRM1AKR1A1CHRM3
SCHEMBL2332757 0.88 CHRM1 (0.33) KMT2APOLBCHRM1AKR1A1CHRM3
SCHEMBL562792 0.87 MGAM (0.35) MGAMGAASIMGAM2FAAH
SCHEMBL2322660 0.87 MGAM (0.35) MGAMGAASIMGAM2FAAH
Hydrochloric Acid SCHEMBL6226702 0.86 MGAM (0.34) MGAMGAASIMGAM2FAAH
SCHEMBL2324298 0.83 CHRM1 (0.36) POLBCHRM1AKR1A1CHRM3HTR2A
SCHEMBL2324304 0.83 CHRM1 (0.36) POLBCHRM1AKR1A1CHRM3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338621-B2 Process for the preparation of 2-oxo-1-pyrrolidine derivatives UCB S.A. (BE) 2012-12-25 US disclosed
EP-1806339-B1 Process for the preparation of 2-oxo-1-pyrrolidine derivatives UCB PHARMA SA (BE) 2011-08-17 EP disclosed
US-20080009638-A1 PROCESS FOR THE PREPARATION OF 2-OXO-1-PYRROLIDINE DERIVATIVES UCB S.A. (BE) 2008-01-10 US disclosed
EP-1806339-A1 Process for the preparation of 2-oxo-1-pyrrolidine derivatives UCB, S.A. (BE) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009638-A1 PROCESS FOR THE PREPARATION OF 2-OXO-1-PYRROLIDINE DERIVATIVES CYP2F1, CYP3A5, SULT1E1 MGAM 597/4885GAA 1106/4885SI 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.